Martin Smoragiewicz

2.5k total citations
36 papers, 601 citations indexed

About

Martin Smoragiewicz is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Martin Smoragiewicz has authored 36 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 20 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Martin Smoragiewicz's work include Renal cell carcinoma treatment (10 papers), Cancer Genomics and Diagnostics (7 papers) and Head and Neck Cancer Studies (6 papers). Martin Smoragiewicz is often cited by papers focused on Renal cell carcinoma treatment (10 papers), Cancer Genomics and Diagnostics (7 papers) and Head and Neck Cancer Studies (6 papers). Martin Smoragiewicz collaborates with scholars based in Canada, United States and South Korea. Martin Smoragiewicz's co-authors include Toni K. Choueiri, Wanling Xie, Jennifer J. Knox, Frede Donskov, Brian I. Rini, Georg A. Bjarnason, Ravindran Kanesvaran, Daniel Y.C. Heng, Nils Kroeger and Sun Young Rha and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Lancet Oncology.

In The Last Decade

Martin Smoragiewicz

35 papers receiving 593 citations

Peers

Martin Smoragiewicz
Shaan Dudani Canada
Lina Yin China
Guillaume Mouillet France
Naveen S. Basappa Canada
Victoria Neiman Israel
Tom Waddell United Kingdom
Igor Stukalin Canada
Nathan C. Nussbaum United States
Alyssa Klein United States
Hidekazu Tachibana Japan
Shaan Dudani Canada
Martin Smoragiewicz
Citations per year, relative to Martin Smoragiewicz Martin Smoragiewicz (= 1×) peers Shaan Dudani

Countries citing papers authored by Martin Smoragiewicz

Since Specialization
Citations

This map shows the geographic impact of Martin Smoragiewicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Smoragiewicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Smoragiewicz more than expected).

Fields of papers citing papers by Martin Smoragiewicz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Smoragiewicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Smoragiewicz. The network helps show where Martin Smoragiewicz may publish in the future.

Co-authorship network of co-authors of Martin Smoragiewicz

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Smoragiewicz. A scholar is included among the top collaborators of Martin Smoragiewicz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Smoragiewicz. Martin Smoragiewicz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Higgins, Kevin, Danny Enepekides, Irene Karam, et al.. (2024). Lymph node yield: Impact on oncologic outcomes in oral cavity cancer. Head & Neck. 46(8). 1965–1974. 3 indexed citations
2.
Louie, Alexander V., Liying Zhang, Ian Poon, et al.. (2024). Stereotactic Body Radiotherapy for Extracranial Oligometastatic Disease from Head and Neck Primary Cancers: A Systematic Review and Meta-Analysis. Cancers. 16(5). 851–851. 1 indexed citations
3.
Wang, Xin, Michael H. Wang, Danny Vesprini, et al.. (2024). Mainstream Model of Genetic Testing for Prostate Cancer at a Large Tertiary Cancer Centre. Clinical Genitourinary Cancer. 22(3). 102052–102052. 1 indexed citations
4.
Lee, Melissa, Jessica Weiss, Irene Karam, et al.. (2024). Oropharyngeal Cancer Staging Health Record Extraction Using Artificial Intelligence. JAMA Otolaryngology–Head & Neck Surgery. 150(12). 1051–1051. 3 indexed citations
5.
Du, Yue, Rui Fu, Kelvin Chan, et al.. (2023). Nivolumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Retrospective Tertiary Centre’s Real-World Experience. Current Oncology. 30(10). 8928–8935. 1 indexed citations
6.
Lyons, Frank, et al.. (2023). Sarcopenia in Men With Bone-Predominant Metastatic Castration-Resistant Prostate Cancer Undergoing Ra-223 Therapy. Clinical Genitourinary Cancer. 21(4). e228–e235.e1. 3 indexed citations
7.
Li, Huaqi, Christopher W. Noel, Julie Hallet, et al.. (2023). Interventions for Concerning Patient-Reported Outcomes in Routine Cancer Care: A Systematic Review. Annals of Surgical Oncology. 31(2). 1148–1170. 1 indexed citations
8.
Li, Huaqi, Christopher W. Noel, Julie Hallet, et al.. (2023). Interventions for Concerning Patient-Reported Outcomes in Routine Cancer Care: A Systematic Review. Annals of Surgical Oncology. 31(3). 1495–1496. 1 indexed citations
9.
Forner, David, Florence Mok, Irene Karam, et al.. (2022). Placement technique impacts gastrostomy tube-related complications amongst head and neck cancer patients. Oral Oncology. 130. 105903–105903. 6 indexed citations
10.
Wells, J. Connor, Keyue Ding, Martin Smoragiewicz, et al.. (2022). Complementary Medicine Use Amongst Patients with Metastatic Cancer Enrolled in Phase III Clinical Trials. The Oncologist. 27(3). e286–e293. 4 indexed citations
11.
Parmar, Ambica, Narhari Timilshina, Urban Emmenegger, et al.. (2021). A cost-utility analysis of apalutamide for metastatic castration-sensitive prostate cancer. Canadian Urological Association Journal. 16(3). E126–E131. 6 indexed citations
12.
13.
Khalid, Sidra, Christopher M. Booth, Ignacio Durán, et al.. (2020). Fibroblast Growth Factor Receptor 3 Mutation as a Prognostic Indicator in Patients with Urothelial Carcinoma: A Systematic Review and Meta-analysis. European Urology Open Science. 21. 61–68. 2 indexed citations
14.
Smoragiewicz, Martin, Alex A. Adjei, Emiliano Calvo, et al.. (2020). Design and Conduct of Early Clinical Studies of Immunotherapy: Recommendations from the Task Force on Methodology for the Development of Innovative Cancer Therapies 2019 (MDICT). Clinical Cancer Research. 26(11). 2461–2465. 5 indexed citations
15.
N., Kim, Som D. Mukherjee, Fred Saad, et al.. (2020). Prostate cancer biomarker enrichment and treatment selection (PC-BETS) study: A Canadian cancer trials group phase II umbrella trial for metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 38(15_suppl). 5551–5551. 11 indexed citations
16.
Templeton, Arnoud J., Jennifer J. Knox, Xun Lin, et al.. (2016). Change in Neutrophil-to-lymphocyte Ratio in Response to Targeted Therapy for Metastatic Renal Cell Carcinoma as a Prognosticator and Biomarker of Efficacy. European Urology. 70(2). 358–364. 125 indexed citations
17.
18.
Heng, Daniel Yick Chin, Frede Donskov, Brian I. Rini, et al.. (2015). Third-line therapy in metastatic renal cell carcinoma: Results from the International mRCC Database Consortium.. Journal of Clinical Oncology. 33(7_suppl). 430–430. 5 indexed citations
19.
Smoragiewicz, Martin, Janessa Laskin, Don Wilson, et al.. (2014). Using pet-ct to Reduce Futile Thoracotomy Rates in Non-Small-Cell Lung Cancer: A Population-Based Review. Current Oncology. 21(6). 768–774. 9 indexed citations
20.
Smoragiewicz, Martin, et al.. (2014). Neutropenia and Relative Dose Intensity on Adjuvant FOLFOX Chemotherapy Are Not Associated with Survival for Resected Colon Cancer. Journal of Gastrointestinal Cancer. 45(4). 460–465. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shaan Dudani Breakdown of academic impact, for papers by Lina Yin Breakdown of academic impact, for papers by Guillaume Mouillet Breakdown of academic impact, for papers by Naveen S. Basappa Breakdown of academic impact, for papers by Victoria Neiman Breakdown of academic impact, for papers by Tom Waddell Breakdown of academic impact, for papers by Igor Stukalin Breakdown of academic impact, for papers by Nathan C. Nussbaum Breakdown of academic impact, for papers by Alyssa Klein Breakdown of academic impact, for papers by Hidekazu Tachibana
Rankless by CCL
2026